Scientific Information

Preliminary Scientific Programme

09:00-13:00

COURSE 1 - Fetal intervention for complex anomalies

Coordinators: Liona Poon, Yves Ville, Magdalena Sanz Cortes

  • Advances in the treatment of CDH and fetal endotracheal obstruction (FETO). Results from the TOTAL trial
  • Postnatal management of CDH. From surgery to ECMO
  • Complicated monochorionic pregnancies and in utero treatment. Improvements in laser technique and controversies
  • Neonatal care of twins with twin to twin transfusion syndrome, TAPS and selective fetal growth restriction
  • Different approaches to TTTS management and cardiovascular outcome

09:00-13:00

COURSE 2 - Stress in maternal infant health

Coordinators: Gian Carlo Di Renzo, Manon Benders

  • Stress: What is it?
  • Stress hormones in Maternal Infant Health
  • Mood and anxiety
  • Periconceptional stressors
  • Life course pathways to maternal prenatal stress
  • Stress at labor and delivery
  • Postpartum blues and support
  • Neonatal Stress
  • Long term implications and costs

09:00-13:00

COURSE 3 - Delivery room care

Coordinators: Max Vento, Gerard Visser

  • Cord clamping
  • Exit
  • Respiratory monitoring
  • Oxygenation

13:00-14:00

LUNCH BREAK

14:00-17:00

COURSE 4 - CMV from conception to long term

Coordinator: Yves Ville

14:00-17:00

COURSE 5 - Maternal haematology

Coordinator: Liliana Voto

  • Venous throboembolism diagnosis treatment
  • VTE prophylaxis
  • Immune Thrombocytopenia

14:00-17:00

COURSE 6 - Fetal neonatal brain imaging

Coordinator: Manon Benders, Netherlands

  • Fetal brain imaging
  • Placenta imaging
  • Neonatal imaging

17:30-18:30

PLENARY 1 - OPENING CEREMONY

Speakers: Sir Michael Marmot, United Kingdom, Sultana Razia, Rajshaj, Bangladesh
The future of periconceptional, maternal, fetal, neonatal medicine, ac (after covid)

08:00-09:00

FREE COMMUNICATION 1

08:00-09:00

FREE COMMUNICATION 2

08:00-09:00

FREE COMMUNICATION 3

09:00-11:00

CO-PLENARY 1 - COVID-19


  • Epidemiological data for perinatal COVID
  • Management of COVID positive pregnant women
  • Management of COVID exposed newborns in NICU
  • Cohort follow-up after COVID

09:00-13:00

CO-PLENARY 2 - FETAL GROWTH RESTRICTION


  • Screening and diagnosis
  • Genetics
  • Placenta
  • Maternal life style strategies
  • Fetal brain imaging
  • Advances in management, early vs late FGR
  • Timing, mode of delivery
  • FGR & Stillbirth
  • Neurodevelopment
  • Long term

11:00-11:30

COFFEE BREAK

11:30-13:00

CO-PLENARY 3 - PERINATAL INFECTIONS


  • Universal screening for Hepatitis C in pregnancy
  • Genetic predisposition to severe infection
  • Antibioprophylaxis during labor pros and cons. A neonatal and longer-term perspective
  • Prenatal screening for congenital infections, time to revisit
  • Microbiome

11:30-13:00

CO-PLENARY 4 - LESS DEVELOPED COUNTRIES


  • The challenges of low income resources countries
  • Maternal/fetal Priorities for LMICs
  • Challenges of those born too soon (Global challenges for the neonate)
  • Comments on Africa

13:00-14:00

LUNCH BREAK

14:00-16:00

PARALLEL 1 - NEUROPROTECTION


  • Pre-conception folic acid
  • MgSO 4
  • Preterm
  • Asphyxia, EPO
  • Hypothermia
  • Stroke
  • Development & Family centered care

14:00-16:00

PARALLEL 2 - TIMING OF DELIVERY


  • Induction of labor
  • Elective C-section and long-term outcome
  • Respiratory distress after
  • Debate: Should all women be delivered at 39 weeks
  • Intrauterine fetal death

14:00-16:00

PARALLEL 3 - BIG DATA/OMICS IN PERINATAL MEDICINE


  • How could metabolomics change pediatric health?
  • Early maternal milk metabolome: Dependence on fetal growth trajectories
  • Necrotizing Enterocolitis: A multi-omic approach and the role of the microbiome
  • Perinatology in the era of big data and nanoparticles

16:00-16:30

COFFEE BREAK

16:30-18:00

PARALLEL 4 - PRETERM BIRTH: LIFELONG CONSEQUENCES


  • The preterm infant in adult life
  • Renal outcomes
  • Cardio-metabolic outcomes
  • Respiratory outcomes
  • Developmental and behavioural outcomes
  • Autism and major neurodevelopmental disorders

16:30-18:00

PARALLEL 5 - THYROID DISORDERS AND MATERNAL AND INFANT HEALTH


  • The impact of thyroid hormones on maternal infant health: global perspective
  • Hypo and hyper function of the thyroid gland: what effects and which is more dangerous in pregnancy?
  • The diagnostic criteria and the screenings
  • The iodine status and long-term outcome

18:00-18:30

PLENARY 2 - HAPPY HOUR LECTURE


Environmental enrichment & perinatal brain - Vittorio Gallo, Whashington, USA

08:00-09:00

FREE COMMUNICATION 1

08:00-09:00

FREE COMMUNICATION 2

08:00-09:00

FREE COMMUNICATION 3

09:00-11:00

PLENARY SESSION 3 - PRETERM BIRTH


  • Prediction and prevention of spontaneous preterm birth
  • Fetal inflammatory response syndrome
  • Delivery room care of the preterm infant
  • Consequences of increased survival in extreme premature infants

11:00-11:30

COFFEE BREAK

11:30-13:00

CO-PLENARY 5 - FETAL NEONATAL THERAPY/SURGERY


  • Fetal surgery: Expanding horizons, Ethics and Shortcomings
  • In utero spina bifida repair: Pros and Cons of Open and Fetoscopic repair
  • Integrative spina bifida care in the neonate and later stages in life
  • CDH/ECMO
  • TTTS

11:30-13:00

CO-PLENARY 6 - EARLY LIFE NUTRITION


  • Periconceptional
  • Maternal
  • Neonatal
  • Long term

13:00-14:00

LUNCH BREAK

14:00-16:00

PARALLEL 6 - NEONATAL LESS INVASIVE RESPIRATORY SUPPORT


  • Less Invasive methods for surfactant administration
  • Is non-invasive respiratory support always the best alternative?
  • Oxygen targets in the delivery room and in the NICU
  • Pro and Cons of HFNC
  • Volume Targeted Ventilation: Pro and Cons

14:00-16:00

PARALLEL 7 - MATERNAL & NEONATAL HAEMODYNAMICS


  • Circulatory transition at birth
  • PDA: Close it or leave it alone
  • Blood pressure and tissue oxygenation
  • Neonatal hemodynamics
  • Ultrasound applied to hemodynamics

14:00-16:00

PARALLEL 7 - GENETICS: WHAT IS NEW


  • Preconception carrier screening
  • Which screening test in early pregnancy?
  • NIPT recent advances
  • Should whole exome sequencing be offered to all cases of congenital structural anomalies, both before and after birth?
  • Neonatal screening - genome wide screening

16:00-16:30

COFFEE BREAK

16:00-16:30

PARALLEL 8 - BPD - PATHOGENESIS AND PREVENTION


  • Antenatal factors in BPD
  • BPD: can we agree on a definition?
  • Postnatal steroids for BPD prevention or treatment
  • Long term consequences of neonatal lung injury

16:00-16:30

PARALLEL 9 - LIMITS OF VIABILITY


  • DEBATE: Ethical Issues at the Border of Viability

16:00-16:30

PARALLEL 10 - NUTRITION OF PRETERM INFANT


  • How much enteral protein does a preterm baby require?
  • Parenteral nutrition
  • The evidence base for human donor milk
  • The dangers of too rapid growth

18:00-18:30

PLENARY 4 - CLOSING LECTURE


Gene therapy: the SMA Model - Stefania Corti, Milan, Italy

Accreditations

Tentative List of Speakers

About FIMPP

The International Foundation for Maternal Periconceptional and Peri- Neonatal Medicine was founded in London on 25 September 2019 with the aim not to create a new company but a scientific structure to foster education, research and advocacy in maternal, periconceptional and neonatal medicine and care worldwide, in an integrated way, to promote and disseminate the study, research and knowledge on all aspects of maternal, periconceptional and neonatal medicine in order to attain, by all appropriate means, a higher level of physical and mental health for women, mothers, and their children by improving the quality and provision of care in the world.

To achieve this goal, the Foundation’s mission is to organize an International Congress every two years, Courses in different regions of the world, linked in particular to the already existing Maternal Fetal and Neonatal Medicine Societies, to create Study Groups on topics with great interest, which promote definitions and terminologies in the mother and infant area, and promoting international scientific exchanges, especially among experts in the low middle income countries.

The Foundation is organized into two bodies, one executive, the Board of Directors and the other scientific, the Board of Scientific Advisors. The Board of Directors is coordinated by Prof Gian Carlo Di Renzo and the other Board by Prof Umberto Simeoni together with their founding members.
The Foundation intends to promote various initiatives starting from the year 2021 and to improve professionalism in the mother and infant area, it is developing agreements with an educational platform such as FIGO (FIGO-GLOWM) IPA (International Pediatric Association) ICM (International Confederation of Midwives) and with many other stakeholders (WHO, UNICEF, MoD etc), proposing itself as a scientific interlocutor to promote health and prevention in maternal infant care.

Congress Committees

FIMPP Committees

BOARD OF DIRECTORS
 
 

Scientific Committee

FIMPP Committees

BOARD OF SCIENTIFIC ADVISORS